UMB Bank n.a. Increases Stake in Repligen Co. (NASDAQ:RGEN)

1 min read | January 26, 2025 01:36 AM PST | By Team Kalkine Media

Headlines

  • Significant investment increases by institutional investors in Repligen Co.
  • Mixed analyst ratings but overall positive outlook on future growth.
  • Consistent revenue growth and robust performance metrics.

Repligen Corporation (NASDAQ:RGEN) has been gaining traction among investors and institutional stakeholders with substantial position changes over recent quarters. The fourth quarter of the last fiscal year saw UMB Bank n.a. increasing its stake in the biotechnology company by 49.1%, translating to a holding value of $48,000. This trend mirrors actions by other financial entities such as Champlain Investment Partners LLC, which enhanced its position by 149% in the third quarter, and Dimensional Fund Advisors LP, which raised its stake by 39.4% during the same period.

Repligen's financial performance reflects resilient metrics, with a reported market capitalization of $9.29 billion and a consistent rise in revenue. The company posted an earnings per share of $0.43 in the latest quarter, surpassing analysts' consensus by $0.09. The biotechnology entity's revenue grew by 9.7% year-over-year in its most recent quarterly report. Despite a negative net margin of 3.36%, Repligen achieved a positive return on equity of 3.90%, establishing a framework for optimism among stakeholders for its future earnings prospect.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next